2,3,4,5-tetrahydroxypentanal has been researched along with Cystadenocarcinoma, Serous in 1 studies
Cystadenocarcinoma, Serous: A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hossein, G | 1 |
| Halvaei, S | 1 |
| Heidarian, Y | 1 |
| Dehghani-Ghobadi, Z | 1 |
| Hassani, M | 1 |
| Hosseini, H | 1 |
| Naderi, N | 1 |
| Sheikh Hassani, S | 1 |
1 other study available for 2,3,4,5-tetrahydroxypentanal and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
Topics: Blood Proteins; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cystad | 2019 |